<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ETF Trends &#187; XPH</title>
	<atom:link href="http://www.etftrends.com/tag/xph/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.etftrends.com</link>
	<description>Setting the Pace for Exchange Traded Funds</description>
	<lastBuildDate>Sat, 11 Feb 2012 14:09:57 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>ETF Spotlight: Pharmaceuticals</title>
		<link>http://www.etftrends.com/2011/10/etf-spotlight-pharmaceuticals/</link>
		<comments>http://www.etftrends.com/2011/10/etf-spotlight-pharmaceuticals/#comments</comments>
		<pubDate>Thu, 13 Oct 2011 20:18:47 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[ETF Spotlight]]></category>
		<category><![CDATA[Feature Stories]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[ETF 101]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=66571</guid>
		<description><![CDATA[ETF spotlight on SPDR S&#38;P Pharmaceuticals ETF (NYSEArca: XPH), part of an ongoing series.
Assets: $241.21 million.
Objective: The SPDR S&#38;P Pharmaceuticals ETF tries to reflect the performance of the S&#38;P Pharmaceuticals Select Industry Index, which tracks U.S-listed companies engaged in the pharmaceuticals industry.
Holdings: Top holdings include: Salix Pharma Inc (NasdaqGS: SLXP) 4.57%, Bristol Myers Squibb Co. [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/10/etf-spotlight-pharmaceuticals/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma, Healthcare ETFs in Focus on M&amp;A Talk, Earnings</title>
		<link>http://www.etftrends.com/2011/04/pharma-healthcare-etfs-in-focus-on-ma-talk-earnings/</link>
		<comments>http://www.etftrends.com/2011/04/pharma-healthcare-etfs-in-focus-on-ma-talk-earnings/#comments</comments>
		<pubDate>Mon, 18 Apr 2011 12:29:29 +0000</pubDate>
		<dc:creator>John Spence</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[IYH]]></category>
		<category><![CDATA[Lead]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PPH]]></category>
		<category><![CDATA[VHT]]></category>
		<category><![CDATA[XLV]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=51139</guid>
		<description><![CDATA[Exchange traded funds (ETFs) tracking pharmaceutical and healthcare stocks could see action Monday on news Johnson &#38; Johnson (NYSE: JNJ) is on the prowl for acquisitions and earnings from Eli Lilly (NYSE: LLY).
Swiss device maker Synthes confirmed it is in merger negotiations with J&#38;J, according to reports. Shares of U.K. medical technology company Smith &#38; [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/04/pharma-healthcare-etfs-in-focus-on-ma-talk-earnings/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmaceutical ETFs Look to the Future</title>
		<link>http://www.etftrends.com/2011/01/pharmaceutical-etfs-look-future/</link>
		<comments>http://www.etftrends.com/2011/01/pharmaceutical-etfs-look-future/#comments</comments>
		<pubDate>Sat, 29 Jan 2011 09:00:35 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[EIS]]></category>
		<category><![CDATA[Emerging Markets]]></category>
		<category><![CDATA[Global ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Israel]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=45261</guid>
		<description><![CDATA[Pharmaceutical exchange traded funds (ETFs) are poised to come roaring back after a lackluster 2010. Just say&#8230;yes?
Last year, pharma underperformed as economic crisis and high joblessness led people to cut back on &#8220;non-essentials.&#8221; Unfortunately, prescriptions often got lumped into that class. Cost-consciousness will likely persist, but therein lies the opportunity.

Americans are forecast to fill up [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/01/pharmaceutical-etfs-look-future/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharmaceutical ETFs: Drug Companies Roar Back</title>
		<link>http://www.etftrends.com/2010/11/pharmaceutical-etfs-drug-companies-roar-back/</link>
		<comments>http://www.etftrends.com/2010/11/pharmaceutical-etfs-drug-companies-roar-back/#comments</comments>
		<pubDate>Tue, 16 Nov 2010 19:00:59 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Lead]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=41339</guid>
		<description><![CDATA[Back in the day, Big Pharma&#8217;s block buster drugs were their bread and butter, but those patents are running out. However, the industry&#8217;s fortunes could be turning as new breakthroughs bring pharma companies and related exchange traded funds (ETFs) back from the brink.
Some cases in point:

Bayer and Johnson &#38; Johnson (NYSE: JNJ) have come up [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/11/pharmaceutical-etfs-drug-companies-roar-back/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pharma ETFs Find New Avenues of Growth</title>
		<link>http://www.etftrends.com/2010/10/pharma-etfs-find-new-avenues-of-growth/</link>
		<comments>http://www.etftrends.com/2010/10/pharma-etfs-find-new-avenues-of-growth/#comments</comments>
		<pubDate>Fri, 08 Oct 2010 21:00:10 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=38930</guid>
		<description><![CDATA[Big pharma has been sitting on a cash cow for years, but patents for iconic drugs are nearing expiration. As cheaper generics become mass produced in emerging markets, the pharmaceutical exchange traded funds (ETFs) may mirror the new area of growth for the pharma industry.
Prescription-tracker IMS Health projects that global pharmaceutical sales will increase by [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/10/pharma-etfs-find-new-avenues-of-growth/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ETFs for a Changing Pharma Landscape</title>
		<link>http://www.etftrends.com/2010/08/etfs-changing-pharma-landscape/</link>
		<comments>http://www.etftrends.com/2010/08/etfs-changing-pharma-landscape/#comments</comments>
		<pubDate>Thu, 05 Aug 2010 21:00:10 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=34698</guid>
		<description><![CDATA[Big pharma companies are looking at a changing landscape, not least of which is the fact that many blockbuster drugs are about to lose their patents, opening the doors for generic players. The increased competition may be a boon to pharma exchange traded funds (ETFs).
Executives at big pharmaceutical companies are not sitting idle. They&#8217;re hard [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/08/etfs-changing-pharma-landscape/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Surprise! 5 ETFs That Are Holding Up</title>
		<link>http://www.etftrends.com/2010/06/surprise-5-etfs-that-are-holding-up/</link>
		<comments>http://www.etftrends.com/2010/06/surprise-5-etfs-that-are-holding-up/#comments</comments>
		<pubDate>Wed, 02 Jun 2010 13:00:39 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Trend Following]]></category>
		<category><![CDATA[Airlines]]></category>
		<category><![CDATA[Consumer Discretionary]]></category>
		<category><![CDATA[FAA]]></category>
		<category><![CDATA[Feature Stories]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IAT]]></category>
		<category><![CDATA[IYT]]></category>
		<category><![CDATA[Lead]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Regional Banks]]></category>
		<category><![CDATA[Retail]]></category>
		<category><![CDATA[Transportation]]></category>
		<category><![CDATA[VCR]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://205.186.132.31/?p=30650</guid>
		<description><![CDATA[ It may seem like all doom and gloom in  the markets these days, but surprise, surprise: There are actually some  exchange traded funds (ETFs) that have been holding up relatively well  in the last few months. 
Let&#8217;s face it: most stock-based exchange traded funds (ETFs) are  strikingly lower than they [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/06/surprise-5-etfs-that-are-holding-up/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Bulls May Prevail: Pharmaceutical ETFs</title>
		<link>http://www.etftrends.com/2010/05/bulls-may-prevail-pharmaceutical-etfs/</link>
		<comments>http://www.etftrends.com/2010/05/bulls-may-prevail-pharmaceutical-etfs/#comments</comments>
		<pubDate>Thu, 13 May 2010 21:00:43 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=29013</guid>
		<description><![CDATA[Wouldn’t it be nice to know exactly how the health care bill will affect pharmaceutical companies? Since we don’t, let’s take a look at the state of the biomedical sector and how related exchange traded funds (ETFs) may perform.
Industry executives are sending mixed signals, reports Carol Kopp of Minyanville. On the one hand, they are [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/05/bulls-may-prevail-pharmaceutical-etfs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>4 ETFs for an Uncertain Future</title>
		<link>http://www.etftrends.com/2009/12/4-etfs-uncertain-future/</link>
		<comments>http://www.etftrends.com/2009/12/4-etfs-uncertain-future/#comments</comments>
		<pubDate>Thu, 31 Dec 2009 21:00:38 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Consumer Staples]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[Retail]]></category>
		<category><![CDATA[VDC]]></category>
		<category><![CDATA[XLP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=23032</guid>
		<description><![CDATA[After some decent rallies in the markets and exchange traded funds (ETFs), investors have regained a fraction of their former wealth. But investors are still gripped with uncertainty and safe haven investments still have appeal.
Health care and consumer staples are traditionally safe haven sectors in uncertain times, according to the Motley Fool for The Money [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/12/4-etfs-uncertain-future/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Emerging Markets: The Next Big Driver of Pharmaceutical, Biotech ETFs?</title>
		<link>http://www.etftrends.com/2009/12/emerging-markets-next-big-driver-pharmaceutical-biotech-etfs/</link>
		<comments>http://www.etftrends.com/2009/12/emerging-markets-next-big-driver-pharmaceutical-biotech-etfs/#comments</comments>
		<pubDate>Tue, 15 Dec 2009 23:00:03 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Emerging Markets]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=22188</guid>
		<description><![CDATA[ As emerging markets continue to grow and prosper, it&#8217;s believed that they&#8217;ll be a major driving force behind the pharmaceutical and biotechnology sectors and their respective exchange trade funds (ETFs). 
Leaders in the pharmaceutical industry now feel that countries that drove growth in the last two decades won&#8217;t be the same countries driving growth [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/12/emerging-markets-next-big-driver-pharmaceutical-biotech-etfs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Stocks, ETFs Move Higher as Trade Gap Narrows</title>
		<link>http://www.etftrends.com/2009/12/stocks-etfs-move-higher-as-trade-gap-narrows/</link>
		<comments>http://www.etftrends.com/2009/12/stocks-etfs-move-higher-as-trade-gap-narrows/#comments</comments>
		<pubDate>Thu, 10 Dec 2009 18:00:43 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[KBE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=22147</guid>
		<description><![CDATA[Both stocks and exchange traded funds (ETFs) are nicely higher this morning as news that the nation&#8217;s trade gap narrowed in October offset slightly higher-than-expected weekly jobless claims. 
The Commerce Department reported this morning that the trade deficit for the United States unexpectedly narrowed by 7.6% in October to $32.9 billion. The weak U.S. dollar helped [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/12/stocks-etfs-move-higher-as-trade-gap-narrows/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>ETFs to Play Obama&#8217;s New Policies</title>
		<link>http://www.etftrends.com/2009/11/etfs-play-obamas-new-policies/</link>
		<comments>http://www.etftrends.com/2009/11/etfs-play-obamas-new-policies/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 19:00:20 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Socially Responsible ETFs]]></category>
		<category><![CDATA[Alternative Energy]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Energy]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[IHI]]></category>
		<category><![CDATA[IYH]]></category>
		<category><![CDATA[KWT]]></category>
		<category><![CDATA[NLR]]></category>
		<category><![CDATA[Nuclear Energy]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[Solar]]></category>
		<category><![CDATA[TAN]]></category>
		<category><![CDATA[XBI]]></category>
		<category><![CDATA[XLV]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=20663</guid>
		<description><![CDATA[Each administration brings its own set of policies to the White House. Investing in exchange traded funds (ETFs) may be a prudent way to experience a potential windfall from the country&#8217;s new direction without the high volatility inherent in individual stocks.
ETFs are a good way for investors to capitalize on policy initiatives of the Obama [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/11/etfs-play-obamas-new-policies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Midday Market Update: Wall Street Braces for Economic Reports</title>
		<link>http://www.etftrends.com/2009/09/midday-market-update-wall-street-braces-for-economic-reports/</link>
		<comments>http://www.etftrends.com/2009/09/midday-market-update-wall-street-braces-for-economic-reports/#comments</comments>
		<pubDate>Mon, 28 Sep 2009 17:00:34 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Commodity ETFs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Dow Jones Industrial Average]]></category>
		<category><![CDATA[Energy]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[NASDAQ]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[S&P 500]]></category>
		<category><![CDATA[USO]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=18286</guid>
		<description><![CDATA[U.S. stocks and exchange traded funds (ETFs) got a boost this morning as mergers and acquisitions activity encouraged investors. 
A busy week of economic data is expected on Wall Street this morning, and it could soon sharpen the picture for investors. One of the major reports expected is the monthly reading on the job market, [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/09/midday-market-update-wall-street-braces-for-economic-reports/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>How the Race for a Cancer Drug Could Help Pharmaceutical ETFs</title>
		<link>http://www.etftrends.com/2009/09/how-race-cancer-drug-could-help-pharmaceutical-etfs/</link>
		<comments>http://www.etftrends.com/2009/09/how-race-cancer-drug-could-help-pharmaceutical-etfs/#comments</comments>
		<pubDate>Mon, 07 Sep 2009 17:00:30 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[IHE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=16937</guid>
		<description><![CDATA[ Billions of dollars are being poured into cancer-fighting drugs. But it&#8217;s not just to find a cure &#8211; it&#8217;s also to gain market share in one of the most untapped markets, from a pharmaceutical standpoint. The related exchange traded funds (ETFs) could benefit no matter which company discovers a drug first. 
After largely ignoring [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/09/how-race-cancer-drug-could-help-pharmaceutical-etfs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Midday Market Update: Markets Lose Luster on Earnings Reports</title>
		<link>http://www.etftrends.com/2009/07/midday-market-update-markets-lose-luster-on-earnings-reports/</link>
		<comments>http://www.etftrends.com/2009/07/midday-market-update-markets-lose-luster-on-earnings-reports/#comments</comments>
		<pubDate>Wed, 22 Jul 2009 17:00:04 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Aerospace & Defense]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[XLF]]></category>
		<category><![CDATA[XPH]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=14259</guid>
		<description><![CDATA[ Following a week long winning streak, mixed earnings reports put a damper on investor confidence and send stocks and exchange traded funds (ETFs) see-sawing in morning trading. 
Chipmaker Advanced Micro Dynamics (AMD) reported a second-quarter loss of $0.62/share a far cry from the $0.47/share loss expected by Wall Street.  On the positive side, Wells [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/07/midday-market-update-markets-lose-luster-on-earnings-reports/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

